ATE144530T1 - Glutathionderivat - Google Patents

Glutathionderivat

Info

Publication number
ATE144530T1
ATE144530T1 AT91904331T AT91904331T ATE144530T1 AT E144530 T1 ATE144530 T1 AT E144530T1 AT 91904331 T AT91904331 T AT 91904331T AT 91904331 T AT91904331 T AT 91904331T AT E144530 T1 ATE144530 T1 AT E144530T1
Authority
AT
Austria
Prior art keywords
lower alkoxy
different
hydroxyl
same
alkyl
Prior art date
Application number
AT91904331T
Other languages
English (en)
Inventor
Shinji Ohmori
Kazumi Ogata
Takahiro Sakaue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE144530T1 publication Critical patent/ATE144530T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91904331T 1990-02-17 1991-02-15 Glutathionderivat ATE144530T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3674590 1990-02-17
JP13360090 1990-05-23

Publications (1)

Publication Number Publication Date
ATE144530T1 true ATE144530T1 (de) 1996-11-15

Family

ID=26375835

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904331T ATE144530T1 (de) 1990-02-17 1991-02-15 Glutathionderivat

Country Status (9)

Country Link
US (1) US5541162A (de)
EP (1) EP0469156B1 (de)
KR (1) KR970001509B1 (de)
AT (1) ATE144530T1 (de)
CA (1) CA2050929A1 (de)
DE (1) DE69122812T2 (de)
ES (1) ES2093091T3 (de)
UA (1) UA21900A (de)
WO (1) WO1991012262A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016065A1 (fr) * 1990-04-26 1991-10-31 Senju Pharmaceutical Co., Ltd. Inhibiteur de troubles hepatiques
CA2099346A1 (en) * 1992-07-17 1994-01-18 Shinji Ohmori Lipid metabolism improving composition
US5616563A (en) * 1992-12-07 1997-04-01 University Of Maryland Baltimore Campus Glutathione N-hydroxycarbamoyl thioesters and method of inhibiting neoplastic growth
CA2213266A1 (en) * 1996-09-04 1998-03-04 Hideki Tsuruoka Method for isolation and purification of s-(1,2-dicarboxyethyl) glutathione
US20030203006A1 (en) * 1997-10-29 2003-10-30 Ajinomoto Co. Inc. Immunomodulator
US6197749B1 (en) * 1997-10-29 2001-03-06 Ajinomoto Co., Inc. Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
EP1004302A3 (de) * 1998-10-29 2003-06-04 Ajinomoto Co., Inc. Immunomodulator
RU2178710C1 (ru) * 2001-02-08 2002-01-27 Кожемякин Леонид Андреевич Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений
US6743433B2 (en) * 2001-07-06 2004-06-01 Nicholas V. Perricone Treatment of acne using alkanolamine compositions
US7172905B2 (en) * 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
AU2003247907A1 (en) * 2002-07-05 2004-01-23 University Of Chicago Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
GB0520845D0 (en) * 2005-10-14 2005-11-23 Hofmann Thomas F Salt enhancing compounds and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537718A (en) * 1982-10-26 1985-08-27 Columbia University In The City Of New York Impermeant spectroscopic probes
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
JP2815179B2 (ja) * 1989-07-14 1998-10-27 千寿製薬株式会社 抗炎症および／または抗アレルギー剤
JP2919870B2 (ja) * 1989-09-29 1999-07-19 千寿製薬株式会社 肝障害抑制剤
WO1991016065A1 (fr) * 1990-04-26 1991-10-31 Senju Pharmaceutical Co., Ltd. Inhibiteur de troubles hepatiques
CA2099346A1 (en) * 1992-07-17 1994-01-18 Shinji Ohmori Lipid metabolism improving composition

Also Published As

Publication number Publication date
CA2050929A1 (en) 1991-08-18
EP0469156A1 (de) 1992-02-05
EP0469156A4 (en) 1993-08-04
KR920701240A (ko) 1992-08-11
US5541162A (en) 1996-07-30
DE69122812T2 (de) 1997-03-20
KR970001509B1 (ko) 1997-02-11
ES2093091T3 (es) 1996-12-16
DE69122812D1 (de) 1996-11-28
UA21900A (uk) 1998-04-30
EP0469156B1 (de) 1996-10-23
WO1991012262A1 (fr) 1991-08-22

Similar Documents

Publication Publication Date Title
ATE194335T1 (de) 4,5-diaryloxazol-derivate
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
DE69528005D1 (de) Prolineamid-Derivate
PT705833E (pt) Derivado de dc-89
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
ATE168677T1 (de) Retroviralproteasehemmende verbindungen
EP0628311A4 (de) Antidepressivum.
EP0669324A4 (de) Chinazolin derivate.
EP0758653A4 (de) Imidazolchinazolinderivate
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ATE144530T1 (de) Glutathionderivat
FI952101A0 (fi) Merkaptanfoerening
EP1184373A4 (de) Tricyclische verbindungen
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
MX9206930A (es) Nuevos compuestos
ATE184605T1 (de) Methotrexat-derivate
EP1048649A4 (de) 5-arylpyrrol-derivate
DE69231244D1 (de) Pyrazolothiazolopyrimidin-derivate
TR28240A (tr) Amidotiofosfat türevi ve aktif engrediyan olarak bunu iceren insektisid, nematosid ve akarisid.
EP0887351A4 (de) Dc 107-derivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties